1. POLD2 is activated by E2F1 to promote triple-negative breast cancer proliferation
   Zhen Zhang, 2022, Frontiers in Oncology CrossRef
2. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning
   Guoqing Ouyang et al, 2023, Frontiers in Immunology CrossRef
3. Resveratrol Mediates the Apoptosis of Triple Negative Breast Cancer Cells by Reducing POLD1 Expression
   Zhi-Jie Liang et al, 2021, Frontiers in Oncology CrossRef
4. A Comprehensive Prognostic Analysis of POLD1 in Hepatocellular Carcinoma
   Hui Tang et al, 2022, BMC Cancer CrossRef
5. Dual Antimicrobial and Antiproliferative Activity of TcPaSK Peptide Derived from a Tribolium castaneum Insect Defensin
   Aida Robles-Fort et al, 2021, Microorganisms CrossRef
6. Transcriptome analysis of human cholangiocytes exposed to carcinogenic 1,2-dichloropropane in the presence of macrophages in vitro
   Abigail Ekuban et al, 2022, Scientific Reports CrossRef
7. Integrated WGCNA and PPI Network to Screen Hub Genes Signatures for Infantile Hemangioma
   Miao Xu et al, 2021, Frontiers in Genetics CrossRef
8. Characterization of Hepatocellular Carcinoma Cell Lines Using a Fractionation-Then-Sequencing Approach Reveals Nuclear-Enriched HCC-Associated lncRNAs
   Eugene Yui-Ching Chow et al, 2019, Frontiers in Genetics CrossRef
9. The Mechanism and Prognostic Value of DNA Polymerase δ Subunits in Hepatocellular Carcinoma: Implications for Precision Therapy
   Qing Wang et al, 2022, International Journal of General Medicine CrossRef
10. Scrutinizing Deleterious Nonsynonymous SNPs and Their Effect on Human POLD1 Gene
    Md. Nazmul Islam Bappy et al, 2022, Genetics Research CrossRef